Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARA
NCT06063200Phase 1Completed
- Sponsor
- University of Florida
- Start
- Mar 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methylphenidate in alcohol use disorder (AUD) (2 arms), sponsored by University of Florida. Primary endpoints: Neural responses to alcohol cues at 15 minutes, Self-reported craving to alcohol cues at 15 minutes and 1 more. Started Mar 2024; status: completed.
02
Drugs
methylphenidate
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06063200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06063200.